Rising Prevalence Of Cardiovascular Diseases Boosts The Market: Key Factor Driving The Growth In The Vascular Dementia Market

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Expected Vascular Dementia Market Size During the Forecast Period?
The market size for vascular dementia has seen a fast-paced growth in the past few years. It is projected to increase from $2.92 billion in 2024 to $3.27 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.1%. The growth witnessed in the historical period is linked to factors like increase in healthcare spending, a surge in diagnosed vascular dementia cases, an increase in healthcare practitioners, expansion of public health initiatives, and a rise in diabetes prevalence.

The market size of vascular dementia is predicted to experience accelerated growth in the approaching years, reaching a projected value of $5.11 billion by 2029, marking a compound annual growth rate (CAGR) of 11.8%. The anticipated growth during this forecast period is due to factors such as increasing cognizance of vascular dementia, heightened investments in healthcare, an increasing older population, escalating cases of cardiovascular diseases, and a rise in high blood pressure prevalence. Key trends projected for this forecast period encompass advancements in technology, custom care strategies, telemedicine, gene-based therapies, and artificial intelligence.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20998

What Are the High-Growth Segments in the Vascular Dementia Market?
The vascular dementia market covered in this report is segmented -

1) By Product: Monoclonal Antibodies, Small Molecules, Peptides
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By End User: Hospitals And Clinics, Rehabilitation Centers, Specialty Clinics

Subsegments:
1) By Monoclonal Antibodies: Anti-Amyloid Monoclonal Antibodies, Anti-Tau Monoclonal Antibodies
2) By Small Molecules: Cholinesterase Inhibitors, Glutamate Modulators, Anti-Inflammatory Small Molecules
3) By Peptides: Amyloid-Beta Targeted Peptides, Neuroprotective Peptides, Tau-Targeting Peptides

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20998&type=smp

What Key Drivers Are Expected to Influence Future Vascular Dementia Market Growth?
An upward trend in cardiovascular diseases is predicted to boost the vascular dementia market's growth. Cardiovascular disorders include a variety of ailments that impact the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and high blood pressure. The surge in these conditions is triggered by factors like unhealthy living conditions, poor eating habits, sedentary behavior, escalating stress levels, an aging demographic, and the upsurge of risk factors like obesity, diabetes, and high blood pressure. Cardiovascular diseases amplify the likelihood of vascular dementia by hindering the blood flow to the brain, inducing cognitive deterioration and damage to brain cells due to insufficient oxygen and nutrient supply. For instance, British Heart Foundation data in September 2024 indicated that in the UK, about 7.6 million people are grappling with heart and circulatory diseases, and roughly 4 million males and 3.6 million females live with these diseases. They account for around 27% of all the deaths in the UK, equals to over 170,000 deaths per year, or approximately 480 deaths daily, or one death every three minutes. Consequently, the escalating prevalence of cardiovascular diseases bolsters the vascular dementia market.

Which Companies Hold the Largest Share Across Different Vascular Dementia Market Segments?
Major companies operating in the vascular dementia market are Intermountain Healthcare Inc., CSPC Ouyi Pharmaceutical Co. Ltd., Duke Health, Massachusetts General Hospital, Emory Healthcare Inc., Apollo Hospitals Enterprise Limited, Amedisys Inc., Northwestern Memorial HealthCare, IBS Hospitals Pvt. Ltd., Resverlogix Corp., ProNeurogen Inc., Cyclerion Therapeutics Inc., Aribio Inc., Pinteon Therapeutics Inc., Dementech Neurosciences Ltd., Moleac Pte. Ltd., Isaac Health Inc., Cadabam's Group of Hospitals, Alpha Cognition Inc., Citi Health

What Trends Are Driving Growth in The Acute Hospital Care Market?
Primarily, the vascular dementia market is being dominated by firms that prioritize the development of unique treatments, like multimodal therapies, to retain their market standing. Multimodal therapies involve combining different treatment strategies, including medication, physical rehabilitation, and psychological interventions, to comprehensively tackle a disease. An example of this is the launch of CognivAiD by Moleac, a biopharmaceutical firm based in Singapore, in January 2023 - an innovative, evidence-supported treatment catered towards addressing vascular dementia (VaD), a disorder with limited treatment alternatives. The product is a concoction of active extracts from ginkgo, ginseng, and saffron, substances that have proven useful in significantly reducing cognitive decline in patients with VaD. CognivAiD's unique multimodal approach focuses on the crucial aspects of vascular dementia including vascular protection, vasoregulation, and neuroinflammation. Bolstered by exhaustive clinical tests and a robust safety framework, CognivAiD showcases a newfound, promising treatment for individuals afflicted with VaD.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/vascular-dementia-global-market-report

What Are the Emerging Geographies for The Vascular Dementia Market Growth?
North America was the largest region in the vascular dementia market in 2024. The regions covered in the vascular dementia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Vascular Dementia Market?
2. What is the CAGR expected in the Vascular Dementia Market?
3. What Are the Key Innovations Transforming the Vascular Dementia Industry?
4. Which Region Is Leading the Vascular Dementia Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.